Strategies in the development of new drugs and drug combinations against leprosy, demonstrated on the example of folate and gyrase inhibitors.
D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D007917:Leprostatic Agents / Q000494:pharmacology*; D051379:Mice; D009166:Mycobacterium leprae / Q000187:drug effects* / Q000201:enzymology; D013329:Structure-Activity Relationship; D059005:Topoisomerase II Inhibitors
D004338:Drug Combinations; D005493:Folic Acid Antagonists; D007917:Leprostatic Agents; D059005:Topoisomerase II Inhibitors